Organisation paid for research Program year 2021 Source: CMS Open Payments

Avail Clnical Rsrch

Neither a doctor nor a teaching hospital

Research payments

$14,481

58 payments

Through program year 2021, Avail Clnical Rsrch is reported as receiving $14,481 in research payments, across 58 payments.

By program year

3 rows
Year Kind Amount Payments
2021 Research $1,704 2
2020 Research $5,039 18
2019 Research $7,738 38

Breakdown

Who paid Research payments · program years 2019–2021
  1. Boehringer Ingelheim International GmbH $13,464 57 payments
  2. Boehringer Ingelheim Pharma GmbH & Co.KG $1,017 1 payment
Studies the money was for Research payments · program years 2019–2021
  1. Empagliflozin and Heart failure (HFrEF) $8,497 27 payments
  2. Comparative study in Psoriasis $3,172 4 payments
  3. Empagliflozin and heart failure (HFpEF) $2,811 27 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record